Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

The new authorisation has been granted for a single-dose, pre-filled pen device that requires no ... promising PIONEER 5 trial results for oral semaglutide, and also claim that its current Ozempic ...

Dwindling supplies of Ozempic are fuelling an “exploding” black market for the drug across Australia, as the medical industry is forced to assess which patients need the popular medication the most.

The drug — along with Novo Nordisk’s semaglutide marketed as Wegovy — has been much ... Eli Lilly for importing and marketing the medicine in a single dose pre-filled pen and in a single-dose vial in ...